Search

everythinglearnresearchcommunity

for

Search:↓

Triamcinolone acetonide therapy for hair loss may cause a skin condition called linear lichen planus.

Immune system changes may contribute to female pattern hair loss.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

High S100A4 levels worsen glioblastoma by promoting blood vessel growth.

A new IL6ST gene variant may cause a unique form of hyper-IgE syndrome with skin abscesses and high IgE levels.

A 13-year-old girl was diagnosed with juvenile lupus, showing only hair loss as a symptom.

Autoimmune Polyendocrine Syndromes involve specific combinations of autoimmune diseases.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Itraconazole effectively treated a woman's painful skin condition and hair loss.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

A rare adrenal gland tumor can cause unusual symptoms due to hormone changes.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Upadacitinib may effectively treat resistant lichen planopilaris.

People with acne have more CD4+ immune cells in their skin than healthy people.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

An 11-year-old child with total hair loss may have a genetic autoimmune disease, and the outlook for hair regrowth is not good.

A rare genetic mutation caused unusual skin symptoms in a man with Blau syndrome.

AS101 reduces hair loss from chemotherapy.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

Early diagnosis, intensive therapy, and careful follow-up are crucial for managing overlapping TTP and SLE.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.